|
|
|
|
LEADER |
02024nmm a2200301 u 4500 |
001 |
EB002135033 |
003 |
EBX01000000000000001273090 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
221201 ||| eng |
020 |
|
|
|a 9783031102714
|
100 |
1 |
|
|a Ballinger, James R.
|
245 |
0 |
0 |
|a PET Radiopharmaceuticals
|h Elektronische Ressource
|b Chemical, Biological, and Clinical Data
|c by James R. Ballinger
|
250 |
|
|
|a 1st ed. 2022
|
260 |
|
|
|a Cham
|b Springer International Publishing
|c 2022, 2022
|
300 |
|
|
|a XX, 131 p
|b online resource
|
505 |
0 |
|
|a Chapter 1: Oncology – 18F-labelled agents -- Chapter 2: Oncology – 11C-labelled agents -- Chapter 3: Oncology – 68Ga-labelled agents -- Chapter 4: Oncology – other agents -- Chapter 5: Cardiology – 18F-labelled agents -- Chapter 6: Cardiology – other agents -- Chapter 7: Neurology – 18F-labelled agents -- Chapter 8: Neurology – 11C-labelled agents -- Chapter 9: Neurology – 15O-labelled agents
|
653 |
|
|
|a Nuclear Medicine
|
653 |
|
|
|a Radiology
|
653 |
|
|
|a Nuclear medicine
|
653 |
|
|
|a Oncology
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
490 |
0 |
|
|a PET/CT
|
028 |
5 |
0 |
|a 10.1007/978-3-031-10271-4
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-031-10271-4?nosfx=y
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 616.0757
|
520 |
|
|
|a This book presents in a consistent format data on ~50 PET radiopharmaceuticals in clinical use. Parameters include basic chemical data, normal biodistribution and excretion, activity administered, radiation dosimetry, patient preparation, and clinical utility, together with a few key references. In some cases a representative image is presented. The organisation is first by clinical specialty (oncology, cardiology, neurology) and within each section by radionuclide (F-18, C-11, etc). This book will be of interest mostly to nuclear medicine physicians and trainees, but also to a wider medical community including radiologists, oncologists and radiotherapists
|